Picard Medical, Inc. (PMI) is a publicly traded the market company. As of November 17, 2026, PMI trades at $7.07 with a market cap of $17.78M and a P/E ratio of -1.16. PMI moved +0.14% today. Year to date, PMI is -93.41%; over the trailing twelve months it is -95.51%. Its 52-week range spans $2.65 to $684.00. Rallies surfaces PMI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Picard Medical Q3 2026 net loss narrows 79% to $2.2 million: Picard Medical's third-quarter 2026 net loss narrowed 79% to $2.2 million, while revenue fell 83% to approximately $200,000. The company had approximately $67,000 in cash at September 30 and said additional financing is needed, with substantial doubt about its ability to continue operating.
| Metric | Value |
|---|---|
| Price | $7.07 |
| Market Cap | $17.78M |
| P/E Ratio | -1.16 |
| EPS | $-7.91 |
| Dividend Yield | 0.00% |
| 52-Week High | $684.00 |
| 52-Week Low | $2.65 |
| Volume | 18.88K |
| Avg Volume | 0 |
| Revenue (TTM) | $6.30M |
| Net Income | $-27.99M |
| Gross Margin | 18.60% |
PMI analyst coverage data. Average price target: $0.00.